Immuno-Oncology News

May 17, 2019May 17, 2019

First Patients Dosed in iTeos’ Experimental A2A Receptor Antagonist Trial for Solid Tumors

This post was originally published on this siteThis post was originally published on this site iTeos Therapeutics’ Phase 1/1b clinical trial testing its ... Read more

May 14, 2019May 14, 2019

$4.6M CIRM Grant to Fund Phase 1 Trial of New Immunotherapy for Advanced Sarcoma, Difficult-to-Treat Cancers

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The California Institute for Regenerative Medicine (CIRM) has ... Read more

May 8, 2019May 8, 2019

Gritstone to Move Slate Immunotherapy into Clinical Trial Sooner than Anticipated

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Gritstone Oncology is advancing its investigational immunotherapy Slate ... Read more

May 7, 2019May 7, 2019

Combining Radiation with Immune Checkpoint Inhibitors Improved Outcomes in Glioblastoma Mice

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Combining radiation therapy with immune checkpoint inhibitors induces ... Read more

May 3, 2019May 3, 2019

Sound Biologics to Launch Phase 1 Trial Assessing Its Candidate Immunotherapy for Solid Tumor Patients

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Sound Biologics is launching a Phase 1 trial ... Read more

April 30, 2019May 1, 2019

Keytruda-Inlyta Combo Approved by FDA for Untreated Advanced Kidney Cancer

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

April 26, 2019April 27, 2019

PureTech Presents Data About Two Promising Anti-cancer Therapies

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site PureTech Health is developing two promising candidate therapies that ... Read more

April 24, 2019April 24, 2019

Aprea’s APR-246 Stabilizes Key Tumor Suppressor Protein and Boosts Immune Responses in Mouse Study

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Aprea Therapeutics‘ APR-246 stabilizes the tumor suppressor protein ... Read more

April 23, 2019April 23, 2019

Melanomas with NF-kB Activation Are Easier to Target with Immune Checkpoint Inhibitors, Study Says

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Melanomas with a high number of genetic mutations ... Read more

April 17, 2019April 17, 2019

BioAtla and BeiGene Enter Collaboration to Develop BioAtla’s BA3071 Cancer Therapy

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site BioAtla and BeiGene entered into a collaboration agreement ... Read more